MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202418044159 A) filed by National University Corporation Kagawa University; and Setolas Holdings, Inc. on June 07, 2024, for Osmotic Pressure Regulator For Peritoneal Dialysate Containing D-Allose And/Or D-Allulose.
Inventors include Minamino, Tetsuo; Ozaki, Taro; Yoshihara, Akihide; and Izumori, Ken.
The application for the patent was published on June 26, 2026, under issue no. 26/2026.
Abstract: Provided is an improved glucose-containing peritoneal dialysate, an ophthalmic composition, or an infusion that can suppress a blood glucose level increase even when used in a long-term treatment and can also suppress an infectious disease, by only addition. A D-glucose-containing osmotic pressure regulator includes D-allose and/or D-allulose as an additive for suppressing a blood glucose level increase by continuous absorption of glucose into the body and for suppressing an infectious disease. The osmotic pressure regulator is used as a mixture with a peritoneal dialysate, an ophthalmic composition, or an infusion. A peritoneal dialysis method for suppressing a blood glucose level increase by continuous absorption of glucose into the body through peritoneal dialysis and for suppressing an infectious disease uses a dialysate containing D-allose and/or D-allulose in an effective amount.
Disclaimer: Curated by HT Syndication.
